Related Experiment Video
Updated: Aug 28, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Gabapentin Can Improve Irritability and Feeding Tolerance in Single Ventricle Interstage Patients: A Case Series
Catherine C Allen1, Karoline Canada2, Sarah Schlueter2
1Division of Pediatric Cardiology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. ccallen@pediatrics.wisc.edu.
Insights
Gabapentin may help infants with single ventricle heart conditions who experience visceral hyperalgesia, leading to feeding intolerance. Four out of five infants showed improvement within 48 hours of treatment.
Area of Science:
- Pediatric Gastroenterology
- Cardiology
- Pharmacology
Background:
- Visceral hyperalgesia is prevalent in children with complex medical issues.
- Infants with single ventricle congenital heart disease (CHD) often exhibit feeding intolerance and irritability during the interstage period.
Observation:
- This case series evaluated gabapentin's efficacy in treating visceral hyperalgesia in single ventricle interstage patients.
- Five patients were included in the study.
Findings:
- Four out of five patients experienced symptomatic improvement within 48 hours of initiating gabapentin therapy.
- Gabapentin demonstrated a positive response in the majority of the observed cases.
Implications:
- Gabapentin shows promise as a treatment for visceral hyperalgesia in single ventricle interstage patients.
- Further multi-center prospective studies are warranted to confirm these preliminary findings and establish treatment guidelines.
Abstract:
Visceral hyperalgesia is common among children with complex medical conditions. Infants with complex congenital heart disease, specifically single ventricle interstage patients, are often found to have feeding intolerance and irritability. Gabapentin treatment has shown promise for symptomatic improvement for visceral hyperalgesia in some patients. We present a case series of five patients in which four of the five patients showed improvement within 48 h of starting gabapentin. The use of gabapentin in single ventricle interstage patients to treat visceral hyperalgesia shows promise based on our case series, but future multi-center prospective studies would be beneficial.
More Related Videos
06:46Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry CIS-FSCV to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Aneurysm IV: Nursing Management
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Mitral Stenosis IV: Nursing Management